Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Profusa Inc (PFSA)

Profusa Inc (PFSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Profusa Announces 1-for-25 Reverse Stock Split GlobeNewswire - Thu Jul 2, 10:00AM CDT

BERKELEY, California, July 02, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology...

PFSA : 2.12 (-16.54%)
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts GlobeNewswire - Wed Jun 24, 7:00AM CDT

BERKELEY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces that shareholders approved all...

PFSA : 2.12 (-16.54%)
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform GlobeNewswire - Fri Jun 12, 7:00AM CDT

BERKELEY, CA, June 12, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, today announces that it has submitted its...

PFSA : 2.12 (-16.54%)
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting GlobeNewswire - Wed Jun 10, 7:00AM CDT

BERKELEY, CA, June 10, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a leading digital health company pioneering next-generation biosensing technologies,...

PFSA : 2.12 (-16.54%)
Profusa Announces Listing Transfer to The Nasdaq Capital Market GlobeNewswire - Fri May 15, 6:30AM CDT

BERKELEY, CA, May 15, 2026 (GLOBE NEWSWIRE) --  Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a  digital health company pioneering the next generation of technology platform enabling...

PFSA : 2.12 (-16.54%)
A concept image of a green and yellow motherboard_ Image by Gorodenkoff via Shutterstock_
2 Reasons Quantum Cyber Has More Than Doubled Today Barchart - Thu May 14, 3:36PM CDT

Quantum Cyber stock more than doubles on an exclusive agreement with BP United and Peter O’Rourke’s appointment as a director. Find out more!

PFSA : 2.12 (-16.54%)
QUCY : 1.3600 (-4.90%)
Profusa Receives Favorable Nasdaq Listing Determination GlobeNewswire - Fri May 8, 5:00AM CDT

BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a  digital health company pioneering the next generation of technology platform enabling...

PFSA : 2.12 (-16.54%)
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value GlobeNewswire - Tue May 5, 7:30AM CDT

Company focusing resources on near-term commercial milestones; European CE Mark process and Healthcare Research revenue opportunities Process intended to evaluate strategic growth alternatives to enhance...

PFSA : 2.12 (-16.54%)
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform GlobeNewswire - Mon Apr 6, 5:00AM CDT

Company secures scalable multi-omics diagnostics platform and launches Mayo Clinic partnership adding to Lumee real-time biochemistry monitoring platform to advance pancreatic cancer applications BERKELEY,...

PFSA : 2.12 (-16.54%)
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering GlobeNewswire - Fri Feb 27, 8:15AM CST

After Reevaluating its Near-term Capital Needs Given the Recent Changes in its Projected 2026 Revenue and Mayo Collaboration, the Company Determined that a $15 Million Offering is Not Required to Achieve...

PFSA : 2.12 (-16.54%)

Barchart Exclusives

Forget GPUs. Nvidia’s Next AI Gold Mine Could Be Even Bigger. Barchart - Sun Jul 12, 3:01PM CDT
Wall Street sees Nvidia's Vera CPU as a major growth catalyst that could expand its AI leadership beyond graphics chips. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.